BRAF class 1–mutant colorectal cancers were significantly more likely to be CMS1 (OR = 6.68; P = 0.024) and significantly less likely to be CMS2 (OR = 0.01; P = 0.01) than cancers in the other two BRAF classes. This evidence concerns the gene BRAF and colorectal cancer.